Correspondence on “Current Controversy in Prenatal Diagnosis: The Use of cfDNA to Screen for Monogenic Conditions in Low Risk Populations Is Ready for Clinical Use”

Documenti analoghi

• Prenatal Screening Via cfDNA – Paired‐End Sequencing Utilizing Fragment Size Information Reduces the Screen Positive Rate for X Chromosome Aneuploidies
  di: Susan Hancock, et al.
  Pubblicazione: (2026)
• Persistent Uninterpretable or Failed Prenatal Cell‐Free DNA Screening Indicates a High‐Risk Pregnancy and is Associated With Biological Factors Interfering With cfDNA‐Analysis: A Prospective Cohort Study
  di: L. Lannoo, et al.
  Pubblicazione: (2025)
• Response to the correspondence on “Performance of single‐gene noninvasive prenatal testing for autosomal recessive conditions in a general population setting”
  di: Julia Wynn, et al.
  Pubblicazione: (2024)
• Celocentesis for Prenatal Diagnosis of Rare Monogenic Diseases: Development, Validation, and Clinical Outcome on 876 Cases
  di: Antonino Giambona, et al.
  Pubblicazione: (2026)
• Blazing the Trail of Non‐Invasive Prenatal Screening Expanded Use: Healthcare Providers' Perspectives
  di: Tierry M. Laforce, et al.
  Pubblicazione: (2025)